Total Payments
$18,503
2024 Payments
$160.84
Companies
93
Transactions
1,013
Medicare Patients
3,597
Medicare Billing
$423,290
Payment Breakdown by Category
Food & Beverage$15,090 (81.6%)
Education$1,464 (7.9%)
Travel$1,458 (7.9%)
Other$465.76 (2.5%)
Gifts$25.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,090 | 982 | 81.6% |
| Education | $1,464 | 22 | 7.9% |
| Travel and Lodging | $1,458 | 3 | 7.9% |
| Long term medical supply or device loan | $465.76 | 5 | 2.5% |
| Gift | $25.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $2,344 | 39 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,197 | 55 | $0 (2023) |
| Amgen Inc. | $1,096 | 56 | $0 (2023) |
| Merck Sharp & Dohme LLC | $951.15 | 70 | $0 (2023) |
| Janssen Biotech, Inc. | $910.85 | 61 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $878.48 | 50 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $833.64 | 81 | $0 (2023) |
| Seagen Inc. | $828.94 | 34 | $0 (2023) |
| Genentech USA, Inc. | $752.51 | 64 | $0 (2023) |
| GENZYME CORPORATION | $520.49 | 29 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $160.84 | 4 | Lilly USA, LLC ($101.43) |
| 2023 | $2,138 | 100 | Novartis Pharmaceuticals Corporation ($301.57) |
| 2022 | $3,686 | 182 | Novartis Pharmaceuticals Corporation ($348.97) |
| 2021 | $2,922 | 170 | Seagen Inc. ($344.28) |
| 2020 | $1,691 | 107 | AstraZeneca Pharmaceuticals LP ($240.68) |
| 2019 | $4,139 | 173 | Celgene Corporation ($1,824) |
| 2018 | $2,040 | 145 | Merck Sharp & Dohme Corporation ($197.19) |
| 2017 | $1,726 | 132 | Genentech USA, Inc. ($225.22) |
All Payment Transactions
1,013 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Oncology | ||||||
| 10/21/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardiology | ||||||
| 06/03/2024 | Lilly USA, LLC | — | Education | In-kind items and services | $101.43 | General |
| 02/28/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $29.25 | General |
| 08/29/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $11.17 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 08/26/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: HORMONE THERAPY | ||||||
| 08/22/2023 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: Oncology | ||||||
| 08/21/2023 | Seagen Inc. | — | Education | In-kind items and services | $57.99 | General |
| 08/21/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: Oncology | ||||||
| 08/21/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Oncology | ||||||
| 08/14/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.96 | General |
| 08/11/2023 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: ONCOLOGY | ||||||
| 08/09/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: ONCOLOGY | ||||||
| 08/09/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Oncology | ||||||
| 08/08/2023 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: BioOncology | ||||||
| 08/05/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: ONCOLOGY | ||||||
| 08/03/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: ONCOLOGY | ||||||
| 08/03/2023 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Oncology | ||||||
| 08/01/2023 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Oncology | ||||||
| 08/01/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Oncology | ||||||
| 08/01/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $18.40 | General |
| Category: Hematology | ||||||
| 07/31/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.06 | General |
| 07/27/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.90 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 849 | 1,530 | $215,681 | $102,504 |
| 2022 | 11 | 862 | 1,533 | $288,787 | $98,076 |
| 2021 | 11 | 908 | 1,486 | $394,705 | $113,472 |
| 2020 | 10 | 978 | 1,613 | $308,803 | $109,238 |
Total Patients
3,597
Total Services
6,162
Medicare Billing
$423,290
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 238 | 503 | $72,432 | $32,206 | 44.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 95 | 231 | $49,434 | $23,181 | 46.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 109 | 229 | $23,816 | $13,167 | 55.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 89 | 101 | $29,391 | $12,691 | 43.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 73 | 125 | $18,625 | $10,802 | 58.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 60 | 94 | $5,640 | $3,194 | 56.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 85 | $8,330 | $3,088 | 37.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $4,573 | $2,053 | 44.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $2,376 | $1,079 | 45.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 83 | 133 | $1,064 | $1,043 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 236 | 468 | $67,392 | $29,578 | 43.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 116 | 224 | $47,936 | $23,763 | 49.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 113 | 245 | $25,480 | $12,938 | 50.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 73 | 80 | $23,280 | $10,748 | 46.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 52 | 79 | $11,771 | $5,941 | 50.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 61 | 182 | $10,920 | $5,222 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 124 | $12,152 | $5,118 | 42.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $3,960 | $1,930 | 48.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $3,497 | $1,714 | 49.0% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2022 | 15 | 15 | $81,735 | $877.56 | 1.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 64 | 83 | $664.00 | $245.61 | 37.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 292 | 559 | $79,858 | $41,603 | 52.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 89 | 187 | $39,647 | $21,015 | 53.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 77 | 85 | $24,735 | $13,007 | 52.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 109 | 224 | $23,272 | $12,307 | 52.9% |
About Dr. William Skinner, M.D
Dr. William Skinner, M.D is a Specialist healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376657254.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Skinner, M.D has received a total of $18,503 in payments from pharmaceutical and medical device companies, with $160.84 received in 2024. These payments were reported across 1,013 transactions from 93 companies. The most common payment nature is "Food and Beverage" ($15,090).
As a Medicare-enrolled provider, Skinner has provided services to 3,597 Medicare beneficiaries, totaling 6,162 services with total Medicare billing of $423,290. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Medical Oncology
- Location Paducah, KY
- Active Since 08/18/2006
- Last Updated 05/31/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1376657254
Products in Payments
- KEYTRUDA (Biological) $861.76
- OPDIVO (Biological) $591.74
- KISQALI (Drug) $535.83
- IMBRUVICA (Drug) $390.61
- DARZALEX (Biological) $266.72
- BRUKINSA (Drug) $266.48
- XTANDI (Drug) $263.30
- Lenvima (Drug) $248.57
- IMFINZI (Drug) $234.01
- LIBTAYO (Biological) $233.96
- ERLEADA (Drug) $231.63
- TAGRISSO (Drug) $219.82
- ZEJULA (Drug) $217.81
- Imbruvica (Drug) $214.13
- JEVTANA (Drug) $185.49
- TUKYSA (Drug) $182.99
- GILOTRIF (Drug) $182.92
- MONJUVI (Drug) $181.98
- IBRANCE (Drug) $178.16
- NERLYNX (Drug) $178.02
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Paducah
Mr. William Hogancamp, M.d, M.D
Specialist — Payments: $11,541
Specialist $11,541
Dr. Stanley Hahn, Md, MD
Specialist — Payments: $6,913
Specialist $6,913
Dr. Kevin Stigall, M.d, M.D
Specialist — Payments: $175.09
Specialist $175.09
Charles Scowcroft, M.d, M.D
Specialist — Payments: $142.14
Specialist $142.14
Mr. Charles Shields, Md, MD
Specialist — Payments: $67.54
Specialist $67.54
Harry Carloss, M.d, M.D
Specialist
Specialist